Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000079098 | SCV000110967 | benign | not specified | 2014-11-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000079098 | SCV000304713 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000079098 | SCV000519687 | benign | not specified | 2016-03-01 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Athena Diagnostics Inc | RCV000710178 | SCV000614671 | benign | not provided | 2017-07-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002311565 | SCV000846188 | benign | Inborn genetic diseases | 2014-11-24 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Invitae | RCV001079548 | SCV001000358 | benign | Hereditary spastic paraplegia 2 | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001789126 | SCV002031495 | benign | Pelizaeus-Merzbacher disease | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001079548 | SCV002031496 | benign | Hereditary spastic paraplegia 2 | 2021-10-25 | criteria provided, single submitter | clinical testing | |
Genome Diagnostics Laboratory, |
RCV001847653 | SCV002105481 | benign | Hereditary spastic paraplegia | 2016-12-12 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000079098 | SCV004804420 | benign | not specified | 2024-01-11 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000079098 | SCV000152314 | likely benign | not specified | no assertion criteria provided | clinical testing | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. | |
Diagnostic Laboratory, |
RCV000079098 | SCV001743297 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000079098 | SCV001929959 | benign | not specified | no assertion criteria provided | clinical testing |